Follow Alto Neuroscience. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
6 Stories in coverage 0 Programs 33 recruiting Registered trials 10-Q Nov 10 Latest SEC filing Nov 10 Latest story
Timeline 6 Pipeline 0 Trials 3
Details
Headquarters Mountain View, CA Incorporated Delaware Industry Pharmaceutical Preparations Also known as Alto Neuroscience, Inc., ANRO How the company describes itself Alto Neuroscience develops small-molecule therapeutics for psychiatric disorders including treatment-resistant depression, major depressive disorder, bipolar depression, and schizophrenia. The clinical-stage company uses a platform measuring EEG activity and neurocognitive data to identify patient treatment response. source